MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Nucleotide repeats as genetic risk factors in a Swedish Parkinson’s disease cohort

J. Laffita Mesa, L. Brodin, P. Svenningsson (Stockholm, Sweden)

Meeting: 2018 International Congress

Abstract Number: 1319

Keywords: Gait disorders: Etiology and Pathogenesis, Gait disorders: Genetics, Spinocerebellar ataxia

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To search for abnormal NRE in the following genes: ATXN2, ATXN3, CACNA1A, TBP, c9orf72, PRNP, POLG1A and TOMM40 in a Swedish PD cohort.

Background: Parkinson’s disease (PD) is the second most frequent neurodegenerative disorder after Alzheimer’s disease. Genetic alterations have been proposed as key risk factors associated with PD. Nucleotide Repeat Expansions (NRE) of variable range in ATXN2, ATXN3, CACNA1A, TBP, c9orf72, PRNP, POLG1A and TOMM40 have been described as significant risk factors for PD and other neurodegenerative diseases. However, these genes have not been analyzed in Swedish PD patients.

Methods: We analyzed DNA samples from 215 Swedish PD patients and 546 ethnically matched controls.

Results: ATXN2: Intermediate CAG repeats expansions in ATXN2 were significantly associated with PD (12/426, 2.77% vs 10/1093 0.91%, p≤0.0003). The specific cut-off for large repeats was 27 CAG repeats. In addition, we found novel structural variations in the ATXN2. Interestingly, CAG repeats ≥42-48 units in TBP were also found in our cohort, (3/426, 0.69% vs 1/1093 0.091, p≤0.04). Also significant association was found between non-10/non-11 alleles in POLG1 and PD (43/422, 10% vs 65/1070, 6%, p≤0.005). TOMM40/ApoE: ApoE alleles were not preferentially associated with PD, the genotype Long-Very/long poly-T sequence in TOMM40 showed to be more frequent in PD 12.20% than in controls 5.98% (p≤0.05). Intermediate or pathological c9orf72 HEX: G4C2 hexa-nucleotides repeats in c9orf72 were also associated with PD (8/213 (1.87%) p≤0.00). Neither pathological poly-Q tails nor insertional nucleotides were present in ATXN3, CACNA1A and PRNP associated with PD.

Conclusions: These data confirmed NRE with abnormal repeats in ATXN2, TBP, POLG1, TOMM40 and c9orf72 as genetic risk factors for PD in the Swedish population. Our results do not support the role of pathological (or conferring risk) expansions or other polymorphisms in ATXN3, CACNA1A and PRNP as genetic risk factors for PD in Sweden.

To cite this abstract in AMA style:

J. Laffita Mesa, L. Brodin, P. Svenningsson. Nucleotide repeats as genetic risk factors in a Swedish Parkinson’s disease cohort [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/nucleotide-repeats-as-genetic-risk-factors-in-a-swedish-parkinsons-disease-cohort/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/nucleotide-repeats-as-genetic-risk-factors-in-a-swedish-parkinsons-disease-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley